Chromium(VI) induced alterations in mouse spleen cells: A short-term assay

Cytobios

Volumn 413, Issue 1 SUPPL., 2001, Pages 27-34

  Das Neves, Ricardo Pires ^a   Santos, Teresa Margarida ^a   Pereira, Maria De Lourdes ^a   De Jesus, Julio Pedrosa ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

Chromium(VI); Spleen cells; Toxicity

Indexed keywords

CARCINOGEN; CHROMIC ACID; CHROMIUM; POTASSIUM CHROMATE(VI); POTASSIUM DERIVATIVE;

ANIMAL; ARTICLE; CYTOLOGY; DRUG EFFECT; HISTOLOGY; MACROPHAGE; MALE; MOUSE; MOUSE STRAIN; SPLEEN; TIME;

ANIMALS; CARCINOGENS; CHROMATES; CHROMIUM; MACROPHAGES; MALE; MICE; MICE, INBRED STRAINS; POTASSIUM COMPOUNDS; SPLEEN; TIME FACTORS;

EID: 0348238820     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. AL-BADER A., Mathew T. C., Khoursheed M., Asfar S., Al-Sayer H. and Dashti H. M. 2000. Thiocetamide toxicity and the spleen: histological and biochemical analysis. Anat. Hist. Embryol. 29 3-8.
2. BARCELOUX D. G. 1999. Chromium. J. Toxicol Clin. Toxicol. 37 173-94.
3. BERINGUE V., Demoy M., Lasmezas C. I., Gouritin B., Weingarten C., Deslys J. P., Andreux J. P., Couvreur P. and Dormont D. 2000. Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J. Path. 190 495-502.
4. CHOWDHURY A. R. and Mitra C. 1995. Spermatogenic and steroidogenic impairment after chromium treatment in rats. Indian J. exp. Biol. 33 480-4.
5. CONNETT P. H. and Wetterhahn K. E. 1983. Metabolism of the carcinogen chromate by cellular constituents. Structure Bonding (Berlin) 54 93-124.
6. COVINGTON A. D. 1997. Modern tanning chemistry. Chem. Soc. Rev. 26 111-26.
7. DARSCH P. C., Hildbrand S., Kimmel R. and Schmahl F. W. 1998. Investigations on the nephrotoxicity and hepatotoxicity of trivalent and hexavalent chromium compounds. Int. Arch. Occup. Environ. Hlth 71 S40-45.
8. DEMOY M., Gibaud S., Andreux J. P., Weingarten C., Gouritin B. and Couvreur P. 1997. Splenic trapping of nanoparticles: complementary approaches for in situ studies. Pharm. Res. 14 463-8.
9. DEMOY M., Andreux J. P., Weingarten C., Gouritin B., Guilloux V. and Couvreur P. 1999a. In vitro evaluation of nanoparticles spleen capture. Life Sci. 64 1329-37.
10. DEMOY M., Andreux J. P., Weingarten C., Gouritin B., Guilloux V. and Couvreur P. 1999b. Spleen capture of nanoparticles: influence of animal species and surface characteristics. Pharm. Res. 16 37-41.
11. DERELANKO M. J., Rinehart W. E., Hilaski R. J., Thompson R. B. and Löser E. 1999. Thirteen-week subchronic rat inhalation toxicity study with a recovery phase of trivalent chromium compounds, chromic oxide and basic chromium sulfate. Toxicol. Sci. 52 278-88.
12. FPS. 1993. Chromium containing waterborne wood preservatives: fixation and environmental issues. 55 pp. J. Lang production coordinator. Forest Product Society, Madison, Wisconsin, U.S.A.
13. GIBAUD S., Demoy M., Andreux J. P., Weingarten C., Gouritin B. and Couvreur P. 1996. Cells involved in the capture of nanoparticles in hematopoietic organs. J. pharm. Sci. 85 944-50.
14. IARC. 1990. Monographs on the evaluation of carcinogenic risks to humans: chromium, nickel and welding, p 49 International Agency for Research on Cancer. Lyon, France.
15. IRONS R. D. 1998. Blood and bone marrow. In Fundamentals of Toxicologic Pathology. pp 215-32. Edited by W. M. Haschek and C. G. Rousseaux. Academic Press, San Diego, U.S.A.
16. KATZ S. A. and Salem H. 1993. The toxicology of chromium with respect to its chemical speciation: a review. J. appl. Toxicol. 13 217-24.
17. KLEIN C. B. 1996. Carcinogenicity and genotoxicity of chromium. Toxicology of metals. pp 205-19. Edited by L. W. Chang, L. Magos and T. Suzuki. CRC Press, U.S.A.
18. LUKANOVA A., Toniolo P., Zhitkovich A., Nikolova V., Panev T., Popov T., Taioli E. and Costa M. 1996. Occupational exposure to Cr(VI): comparison between chromium levels in lymphocytes, erythrocytes, and urine. Int. Arch. Occup. Environ. Hlth 69 39-44.
19. MANCUSO F. M. 1997. Chromium as an industrial carcinogen. II. Chromium in human tissues. Am. J. ind. Med. 31 140-7.
20. MURTHY R. C., Saxena D. K., Gupta S. K. and Chandra S. V. 1991. Ultrastructural observations in testicular tissue of chromium-treated rats. Rep. Toxicol. 5 443-7.
21. NIEBOER E. and Jusys A. A. 1988. Biological chemistry of chromium. In Chromium in the Natural and Human Environments. Advances in Environmental Science and Technology. Vol 20 pp 21-79. Wiley Interscience.
22. OUTRIDGE P. M. and Scheuhammer A. M. 1993. Bioaccumulation and toxicology of chromium: implications for wildlife. Rev. Environ. Contam. Toxicol. 130 31-77.
23. PEREIRA M. C., Pereira M. L. and Sousa J. P. 1999. Histological effects of iron accumulation on mice liver and spleen after administration of a metallic solution. Biomaterials 20 2193-8.
24. PEREIRA M. C., Pereira M. L. and Sousa J. P. 1998. Evaluation of nickel toxicity on liver, spleen, and kidney of mice after administration of high-dose metal ion. J. biomed. Mater. Res. 40 40-7.
25. SANTOS T. M. 1995. Chromium co-ordination chemistry related with biological effects of Cr(III) and Cr(VI) compounds. PhD Thesis, University of Aveiro.
26. SHI X., Chiu A., Chen C. T., Halliwell B., Castranova V. and Vallyathan V. 1999. Reduction of Cr(VI) and its relationship to carcinogenesis. J. Toxicol. Environ. Hlth Part B, 2 87-104.
27. SINGH J., Carlisle D. L. and Patierno S. R. 1998. Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). Oncol. Rep. 5 1307-18.
28. SINGH J., Pritchard D. E., Carlisle D. L., Mclean J. A., Montaser A., Orenstaein J. M. and Patierno S. R. 1999. Internalisation of carcinogenic lead chromate particles by cultural normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicol. appl. Pharmacol. 161 240-8.
29. SOLIS-HEREDIA M. J., Ouintanilla-Vega B., Sierra-Santoyo A., Hernandez J. M., Brambila E., Cébrian M. E. and Albores A. 2000. Chromium increases pancreatic metallothionein in the rat. Toxicology 142 111-7.
30. STANDEVEN A. E. and Wetterhahn K. E. 1989. Chromium(VI) toxicity: uptake, reduction and DNA damage. J. Am. Coll. Toxicol. 8 1275-83.
31. SUGIYAMA M. 1992. Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free Rad. Biol. Med. 12 397-407.
32. TOYA T., Fukuda K., Kohyama N., Kyono H. and Arito H. 1999. Hexavalent chromium responsible for lung lesions induced by intratracheal instillation of Cr fumes in rats. Ind. Hlth 37 36-46.
33. YUANN J. M., Liu K. J., Hamilton J. W. and Wetterhahn K. E. 1999. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of Cr(V), Cr-DNA binding and 8-hydroxy-2′-deoxyguanosine in liver and kidney of osteogenic disorder in Shionogi rats following treatment with Cr(VI). Carcinogenesis 20 1267-75.
34. ZIKTOVICH A., Voitkun V., Kluz T. and Costa M. 1998. Utilisation of DNA-protein cross-links as a biomarker of chromium exposure. Environ. Hlth Perspect. 106 969-74.